Bibliografia UJ CM

1/9
P. Berlanga, C. Pasqualini, U. Potschger, C. Sanguesa, M.R. Castellani, A. Canete, R. Luksch, M. Elliot, G. Schreier, M. Kropf, D. Morgenstern, V. Papadakis, S. Ash, E. Ruud, P. Brock, A[leksandra] Wieczorek, P. Kogner, T. Trahair, P. Ambros, T. Boterberg, V. Castel, D. Valteau-Couanet, R. Ladenstein.
Central nervous system relapse in high-risk stage 4 neuroblastoma : The HR-NBL1/SIOPEN trial experience.
European Journal of Cancer
2021 : Vol. 144, s. 1-8, il., bibliogr. 17 poz., abstr.
Autor korespondencyjny: P. Berlanga.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0959-8049
AZ
ORG
AIF
IF: 10.002
Adres url:
Streszczenie w PubMed:
2/9
R. Ladenstein, U. Poetschger, D. Valteau-Couanet, J. Gray, R. Luksch, W[alentyna] Balwierz, V. Castel, S. Ash, M. Beck-Popovic, G. Laureys, G. Chi Fung Chan, E. Ruud, K. Vettenranta, C. Owens, H. Schroeder, P. Ambros, S. Sarnacki, T. Boterberg, H. Lode.
Prognostic Risk Factors in the HR-NBL-1/SIOPEN Study in Patients Receiving Dinutuximab Beta (DB) Based Immunotherapy.
Pediatric Blood & Cancer
2020 : Vol. 67, suppl. 4, s. S265, abstr. 0586
Abstracts from the 52th Congress of the International Society of Paediatric Oncology (SIOP) Virtual Congress, October 14-17, 2020.
p-ISSN: 1545-5009
SZZ
SIF
Adres url:
3/9
R. Ladenstein, U. Poetschger, T. Boterberg, K. Dieckmann, S. Bolle, K. Holmes, S. Sarnacki, J. Gomez-Chacon, P. Brock, R. Luksch, S. Ash, W[alentyna] Balwierz, E. Ruud, V. Papadakis, C. Owens, J. Stenman, H. Schroeder, T. Trahair, D. Valteau-Couanet, M. Gaze.
Success of the HR-NBL1/SIOPEN Trial Local Control Strategy in High-Risk Neuroblastoma Patients Receiving High-Dose Therapy and Stem Cell Transplantation.
Pediatric Blood & Cancer
2018 : Vol. 65, suppl. 2, s. S261-S262, abstr. PO-372.
p-ISSN: 1545-5009
SZZ
SIF
4/9
R. Ladenstein, U. Poetschger, S. Sarnacki, T. Monclair, G. Cecchetto, J. Gomez-Chacon, J. Stenman, J.M. Joseph, R. Luksch, V. Castel, S. Ash, V. Papadakis, J. Malis, W[alentyna] Balwierz, C. Owens, H. Lode, T. Boterberg, D. Valteau-Couanet, A.D. Pearson, K. Holmes.
The Influence of Surgical Excision on Survival in High-Risk Neuroblastoma Revisited After Introduction of ch14.18/CHO Immunotherapy in the HR-NBL1/SIOPEN Trial.
Pediatric Blood & Cancer
2018 : Vol. 65, suppl. 2, s. S36-S37, abstr. O-062.
p-ISSN: 1545-5009
SZZ
SIF
5/9
R. Ladenstein, U. Poetschger, D. Valteau-Couanet, V. Castel, M. Elliott, S. Ash, G. Chan, G. Laureys, M. Beck-Popovic, K. Vettenranta, W[alentyna] Balwierz, H. Schroeder, C. Owens, M. Cesen, V. Papadakis, T. Trahair, R. Luksch, G. Schleiermacher, P. Ambros, A. Garaventa.
The Randomised Induction for High-Risk Neuroblastoma Comparing COJEC and N5-MSKCC Regimens. Early Results from the HR-NBL1.5/SIOPEN Trial.
Pediatric Blood & Cancer
2018 : Vol. 65, suppl. 2, s. S11, abstr. O-013.
p-ISSN: 1545-5009
SZZ
SIF
6/9
R. Ladenstein, U. Poetschger, P. Brock, R. Luksch, V. Castel, I. Yaniv, V. Papadakis, G. Laureys, J. Malis, W[alentyna] Balwierz, P. Kogner, P. Ambros, K. Holmes, M. Gaze, G. Schreier, A. Garaventa, G. Vassal, J. Michon, A. Pearson, D. Valteau-Couanet.
Long-Term Results for Children with High-Risk Neuroblastoma Treated on the Randomized High-Dose Therapy Trial of Busulphan-Melphalan Versus Carboplatin-Etoposide-Melphalan: A Siopen Study.
Pediatric Blood & Cancer
2016 : Vol. 63, Suppl. 3, s. S32, abstr. O-106.
48th Congress of the International Society of Paediatric Oncology (SIOP) Dublin, Ireland, October 19-22, 2016.
p-ISSN: 1545-5009
SZZ
SIF
7/9
R. Ladenstein, U. Poetschger, M. Elliot, R. Luksch, V. Castel, I. Yaniv, V. Papadakis, G. Laureys, J. Malis, W[alentyna] Balwierz, E. Ruud, P. Kogner, H. Schroeder, A. Forjaz de Lacerda, M. Beck-Popovic, P. Bician, M. Garami, T. Trahair, P. Ambros, K. Holmes, G. Schreier, M. Gaze, A. Pearson, D. Valteau-Couanet, SIOP Europe Neuroblastoma Grp.
Risk factors in stage 4 neuroblastoma patients treated with Busulphan-Melphalan. Report from the European High Risk Neuroblastoma HR-NBL1/SIOPEN TRIAL.
Bone Marrow Transplantation
2016 : Vol. 51, suppl. 1, s. S46, abstr. O072.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain, APR 03-06, 2016.
p-ISSN: 0268-3369
SZZ
SIF
8/9
R. Ladenstein, U. Poetschger, R. Luksch, M. Elliot, V. Castel, I. Yaniv, G. Laureys, W[alentyna] Balwierz, H.N. Lode, D. Valteau-Couanet.
Myeloablative therapy (MAT) and immunotherapy (IT) with ch14.18/cho for high risk neuroblastoma: update and news of randomised results from the HR-NBL1/SIOPEN trial.
Pediatric Blood & Cancer
2014 : Vol. 61, Suppl. 2, s. S122-S123, abstr. O-063.
p-ISSN: 1545-5009
SZZ
SIF
9/9
U. Thiel, A. Wawer, P. Wolf, M. Badoglio, A. Santucci, T. Klingebiel, O. Basu, A. Borkhardt, H.-J. Laws, Y. Kodera, A. Yoshimi, C. Peters, R. Ladenstein, A. Pession, A. Prete, E.-C. Urban, W. Schwinger, P. Bordigoni, A. Salmon, M.A. Diaz, B. Afanasyev, I. Lisukov, E. Morozova, A. Toren, B. Bielorai, J. Korsakas, F. Fagioli, D. Caselli, G. Ehninger, B. Gruhn, U. Dirksen, F. Abdel-Rahman, M. Aglietta, E. Mastrodicasa, M. Torrent, P. Corradini, F. Demeocq, G. Dini, P. Dreger, M. Eyrich, J[olanta] Gozdzik, F. Guilhot, E. Holler, E. Koscielniak, C. Messina, D. Nachbaur, R. Sabbatini, E. Oldani, H. Ottinger, H. Ozsahin, R. Schots, S. Siena, J. Stein, S. Sufliarska, A. Unal, M. Ussowicz, P. Schneider, W. Woessmann, H. Jurgens, M. Bregni, S. Burdach, Solid Tumor Working Party (STWP), Pediatric DiseaseWorking Party (PDWP), Eur. Group for Blood and Marrow Transplantation, Asia Pacific Blood and Marrow Transplantation, Pediatr. Registry for Stem Cell Transplant. (PRST), MetaEICESS Study Group.
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients.
Annals of Oncology
2011 : Vol. 22, nr 7, s. 1614-1621, il., bibliogr. 31 poz.
p-ISSN: 0923-7534
AZ
ORG
AIF
IF: 6.425
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ